Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClonDoTrial: Clonidine and Doxazosin for PTSD Nightmares
NCT05360953Phase 2Suspended
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jun 2022
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clonidine, doxazosin in post-traumatic stress disorder (PTSD), sponsored by Charité – Universitätsmedizin Berlin. Started Jun 2022; status: suspended.
02
Drugs
clonidinedoxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05360953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05360953.